<DOC>
	<DOCNO>NCT01445028</DOCNO>
	<brief_summary>Proliferative vitreoretinopathy ( PVR ) , secondary scar around retina , important cause retinal re-detachment . The purpose study evaluate effect oral isotretinoin , inhibit growth cell responsible proliferative vitreoretinopathy ( PVR ) , recurrent retinal detachment .</brief_summary>
	<brief_title>Isotretinoin Proliferative Vitreoretinopathy</brief_title>
	<detailed_description>Small retrospective study show isotretinoin effective reduce rate recurrent retinal detachment patient high risk develop PVR . This prospective study evaluate low dose oral isotretinoin regard . There two arm study : 1 ) eye recurrent retinal detachment due exist PVR , 2 ) eye primary detachment feature associate high risk PVR formation . Eligible willing patient receive 12-week course isotretinoin , follow retinal attachment rate , PVR and/or ERM ( epiretinal membrane ) formation .</detailed_description>
	<mesh_term>Vitreoretinopathy , Proliferative</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>1870 yearold men 5070 yearold , postmenopausal woman . Healthy enough participate study . Willing able consent participation . Recurrent PVRassociated RD occur least 2 week RD repair Primary RD ( retinal detachment ) associate one highrisk feature History hypersensitivity isotretinoin . Current use corticosteroid ( exclude topical ) . Any history depression , anorexia , liver pancreatic disease . More one prior surgical RD repair . Patients close funnel retinal detachment . Patients chronic retinal detachment , define longer 12 week . Any use oral retinoid within 6 month . Systemic chemotherapy within 6 month . Patients take supplemental vitamin A. Corneal opacity sufficient impair surgical view . Proliferative diabetic retinopathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>